全文获取类型
收费全文 | 17410篇 |
免费 | 2167篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 180篇 |
儿科学 | 491篇 |
妇产科学 | 431篇 |
基础医学 | 2853篇 |
口腔科学 | 496篇 |
临床医学 | 1941篇 |
内科学 | 3272篇 |
皮肤病学 | 282篇 |
神经病学 | 1559篇 |
特种医学 | 752篇 |
外科学 | 2633篇 |
综合类 | 137篇 |
一般理论 | 12篇 |
预防医学 | 1668篇 |
眼科学 | 202篇 |
药学 | 1424篇 |
中国医学 | 21篇 |
肿瘤学 | 1252篇 |
出版年
2023年 | 118篇 |
2022年 | 91篇 |
2021年 | 245篇 |
2020年 | 209篇 |
2019年 | 307篇 |
2018年 | 459篇 |
2017年 | 387篇 |
2016年 | 411篇 |
2015年 | 369篇 |
2014年 | 436篇 |
2013年 | 802篇 |
2012年 | 1026篇 |
2011年 | 1126篇 |
2010年 | 529篇 |
2009年 | 415篇 |
2008年 | 1003篇 |
2007年 | 1087篇 |
2006年 | 938篇 |
2005年 | 935篇 |
2004年 | 867篇 |
2003年 | 908篇 |
2002年 | 808篇 |
2001年 | 427篇 |
2000年 | 510篇 |
1999年 | 367篇 |
1998年 | 177篇 |
1997年 | 167篇 |
1996年 | 198篇 |
1995年 | 191篇 |
1994年 | 197篇 |
1993年 | 164篇 |
1992年 | 221篇 |
1991年 | 185篇 |
1990年 | 207篇 |
1989年 | 210篇 |
1988年 | 174篇 |
1987年 | 156篇 |
1986年 | 169篇 |
1985年 | 149篇 |
1984年 | 180篇 |
1983年 | 140篇 |
1982年 | 116篇 |
1981年 | 106篇 |
1980年 | 101篇 |
1979年 | 107篇 |
1978年 | 81篇 |
1977年 | 90篇 |
1975年 | 75篇 |
1974年 | 66篇 |
1973年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Unusual Enterobacteriaceae: H2S+ Shigella sonnei, one authentic and one false positive due to contamination with the obligate anaerobe Eubacterium lentum. 下载免费PDF全文
J J Farmer rd C F Riddle M D Stargel H Iida T Aikawa D Achanzar W I Taylor 《Journal of clinical microbiology》1976,3(2):206-208
A mixture of Shigella sonnei and Eubacterium lentum produced H2S in triple sugar iron agar; however, neither produced any in pure culture. A second culture of S. sonnei, isolated in Japan, is thought to be the first documented H2S+ Shigella. 相似文献
102.
103.
Pelin Sahlén Rapolas Spalinskas Samina Asad Kunal Das Mahapatra Pontus Höjer Anandashankar Anil Jesper Eisfeldt Ankit Srivastava Pernilla Nikamo Anaya Mukherjee Kyu-Han Kim Otto Bergman Mona Ståhle Enikö Sonkoly Andor Pivarcsi Carl-Fredrik Wahlgren Magnus Nordenskjöld Fulya Taylan Isabel Tapia-Páez 《The Journal of allergy and clinical immunology》2021,147(5):1742-1752
104.
Gene profiling reveals increased expression of uteroglobin and other anti-inflammatory genes in glucocorticoid-treated nasal polyps 总被引:3,自引:0,他引:3
Benson M Carlsson L Adner M Jernås M Rudemo M Sjögren A Svensson PA Uddman R Cardell LO 《The Journal of allergy and clinical immunology》2004,113(6):58-1143
BACKGROUND: Treatment with local glucocorticoids (GCs) decreases symptoms and the size of nasal polyps. This might depend on the downregulation of proinflammatory genes, as well as the upregulation of anti-inflammatory genes. OBJECTIVE: We sought to identify GC-regulated anti-inflammatory genes in nasal polyps. METHODS: Affymetrix DNA microarrays were used to analyze the expression of 22,283 genes in 4 nasal polyps before and after local treatment with fluticasone (400 microg/d). Expression of uteroglobin and mammaglobin B was analyzed with real-time PCR in 6 nasal polyps and in nasal biopsy specimens from 6 healthy control subjects. RESULTS: Two hundred three genes had changed in expression in treated polyps, and 139 had known functions: 54 genes were downregulated, and 85 were upregulated. Genes associated with inflammation constituted the largest single functional group. These genes affected key steps in inflammation (eg, immunoglobulin production; antigen processing and presentation; and the chemoattraction and activation of granulocytes, T cells, and B cells). Several proinflammatory genes were downregulated. In contrast, some anti-inflammatory genes were upregulated. The gene that increased most in terms of expression was uteroglobin. This was confirmed with real-time PCR. By contrast, expression of uteroglobin was lower in untreated polyps than in healthy nasal mucosa. Immunohistochemical investigation showed staining of uteroglobin in the epithelium and in seromucous glands in control subjects and in nasal polyps. CONCLUSION: Upregulation of anti-inflammatory genes, such as uteroglobin, might contribute to the effects of local treatment with GCs in nasal polyps. 相似文献
105.
Efflux of prostaglandins in lymph from scalded tissues 总被引:1,自引:0,他引:1
106.
Sifil A Bednarz D Larive B Garcia M Lau SM Paganini EP 《ASAIO journal (American Society for Artificial Internal Organs : 1992)》2003,49(6):667-672
The Harmonized Alert Sensing Technology (HASTE) device was developed to overcome the primary shortcomings of interval based noninvasive blood pressure (BP) monitoring. This study was conducted to assess the reliability of the HASTE system compared with standard cuff BP values in patients on hemodialysis. A total of 1,370 HASTE measurements were compared with oscillometric standard cuff systolic BP values in 42 sessions of 15 patients on hemodialysis. The average discrepancy between the HASTE and cuff systolic BP was 1.41 +/- 16.90 mm Hg. Compared with cuff measurements, 31% of systolic BP fell within a range of 5 mm Hg difference, 57% of systolic BP fell within 10 mm Hg, and 73% of systolic BP fell within a 15 mm Hg band. According to British Hypertension Society standards or Association for the Advancement of Medical Instrumentation criteria, the current HASTE method did not perform well. Technology to provide noninvasive hemodynamic monitoring is, however, in its developmental stage. The effort at continuous systolic pressure monitoring using existing, readily available, and frequently used techniques is exciting. Although the HASTE system as currently configured and calibrated did not adequately perform, variations in site analysis and conversion factors may increase pressure sensitivity and tracking over the course of a standard dialysis treatment. 相似文献
107.
The aim of the study was to evaluate the effect of cognitive intervention (information and physical exercise), on patients with long-lasting back pain referred for surgical evaluation at an orthopaedic hospital, but evaluated as unfit for surgery. One hundred and fifty-two patients were randomized to a five days intervention or control. The intervention had no significant effects on pain. At three-month follow-up, the patients in the intervention group used significantly more active strategies to cope with the back pain compared to the control group. This effect seemed to increase over time, being more pronounced at one-year follow-up evaluation. 相似文献
108.
BACKGROUND: (R)- and (S)-Enantiomers of albuterol likely exert differential effects in patients with asthma. The (R)-enantiomer binds to the beta2-adrenergic receptor with greater affinity than the (S)-enantiomer and is responsible for albuterol's bronchodilating activity. (S)-Albuterol augments bronchospasm and has proinflammatory actions. OBJECTIVE: The study aim was to determine whether the (S)-enantiomer, in contrast to the (R)-enantiomer, has adverse effects on allergic airway inflammation and hyperresponsiveness in a mouse asthma model. METHODS: Mice sensitized to ovalbumin (OVA) intraperitoneally on days 0 and 14 were challenged with OVA intranasally on days 14, 25, and 35. On day 36, 24 hours after the final allergen challenge, the effect of the (R)- and (S)-enantiomers of albuterol (1 mg x kg(-1) x d(-1) administered by means of a miniosmotic pump from days 13-36) on airway inflammation and hyperreactivity was determined. RESULTS: In OVA-sensitized/OVA-challenged mice, (R)-albuterol significantly reduced the influx of eosinophils into the bronchoalveolar lavage fluid and airway tissue. (R)-Albuterol also significantly decreased airway goblet cell hyperplasia and mucus occlusion and levels of IL-4 in bronchoalveolar lavage fluid and OVA-specific IgE in plasma. Although (S)-albuterol significantly reduced airway eosinophil infiltration, goblet cell hyperplasia, and mucus occlusion, it increased airway edema and responsiveness to methacholine in OVA-sensitized/OVA-challenged mice. Allergen-induced airway edema and pulmonary mechanics were unaffected by (R)-albuterol. CONCLUSION: Both (R)- and (S)-enantiomers of albuterol reduce airway eosinophil trafficking and mucus hypersecretion in a mouse model of asthma. However, (S)-albuterol increases allergen-induced airway edema and hyperresponsiveness. These adverse effects of the (S)-enantiomer on lung function might limit the clinical efficacy of racemic albuterol. 相似文献
109.
Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome. 总被引:1,自引:0,他引:1
Anthony D Elias Arthur T Skarin Paul Richardson Joseph Ibrahim Mary McCauley Emil Frei 《Biology of blood and marrow transplantation》2002,8(6):326-333
Treatment for extensive-stage small cell lung cancer (ES SCLC) or extrapulmonary small cell carcinoma (EPSC) is typically palliative. We set out to determine progression-free survival (PFS) and overall long-term survival of ES SCLC and EPSC patients, physiologically aged < or = 60 years, responding to first-line chemotherapy followed by high-dose combination alkylating agents with hematologic stem cell support. Patients in first-line chemotherapy response underwent stem cell collection (marrow, peripheral blood progenitor cells, or both) followed by high-dose therapy with 1 of 2 regimens: CBP (cyclophosphamide, cisplatin, and carmustine) or ICE (ifosfamide, carboplatin, and etoposide) with or without etanidazole. Involved-field radiotherapy was given to selected patients with oligometastatic disease distributed in sites allowing for reasonable radiation ports, and prophylactic cranial radiotherapy was given upon recovery to patients in complete response (CR) or near-CR. A total of 36 patients were treated. Of 29 patients with ES SCLC, 6 (21%) had achieved CR, 18 near-CR, and 5 partial response prior to high-dose therapy. Of 7 patients with EPSC, 3 (43%) had achieved CR, 3 had achieved near-CR, and 1 had progression of disease prior to high-dose therapy. Thirteen ES SCLC patients received high-dose CBP. Of the remaining 23 patients with SCLC or EPSC, 17 were treated with ICE and 6 with ICE plus etanidazole, a hypoxic cell sensitizer. Treatment-related mortality was 11% (4 of 36 patients). For all patients, the median event-free survival (EFS) was 5 months. The 2- and 5-year survivals after intensification were 12% (95% confidence interval [CI], 5%-31%) and 9% (95% CI, 3%-27%), respectively. Of the 30 patients in or near CR prior to high-dose therapy, 5 remain continuously progression-free (2 ES SCLC, 3 EPSC) for a median of 55 months (range, 1-96 months) after high-dose therapy. By multivariate analysis, factors associated with more favorable EFS were the use of a more aggressive induction regimen (ICE), and the EPSC histology. These factors were also associated with more favorable overall survival. Other factors associated with more favorable overall survival were the use of short induction therapy (< or = 4 cycles) and younger age (<50 years). Except for high-dose ICE with etanidazole, the use of high-dose systemic therapy in ES SCLC and EPSC was associated with low treatment-related morbidity and mortality over the past 5 years. Late complications were infrequent, and most patients returned to full-time work and activity, barring disease recurrence. Nonetheless, few patients with ES SCLC have progression-free long-term survival. We conclude that high-dose therapy is not indicated as an approach for ES SCLC, except as part of an investigative trial. Conversely, 3 of the 7 patients with EPSC remain relapse-free (range, 1-96 months), warranting further phase II evaluation of this approach in this population. 相似文献
110.
Jesper L. R. Andersson Anders Lilja P. Hartvig Bengt Långström Torsten Gordh Hermann Handwerker E. Torebjörk 《Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale》1997,117(2):192-199
Regional cerebral blood flow was measured with positron emission tomography (PET) in six healthy volunteers at rest and during
experimentally induced, sustained cutaneous pain on the dorsum of the right hand or on the dorsum of the right foot. Pain
was inflicted by intracutaneous injection of capsaicin, providing a mainly C-fibre nociceptive stimulus. Statistical analysis
showed significant activations along the central sulcus (SI) area when comparing pain in the hand to pain in the foot. Separate
comparison of both pain states to a baseline revealed different locations along the central sulcus for hand pain and foot
pain. The encountered differences are consistent with what is previously known about the somatotopics of non-painful stimuli.
When comparing painful stimuli to baseline, the contralateral anterior cingulate gyrus, the ipsilateral anterior insular cortex
and the ipsilateral prefrontal cortex were implicated. The results are consistent with an involvement of SI in the spatial
discrimination of acute cutaneous pain.
Received: 17 October 1996 / Accepted: 12 May 1997 相似文献